blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1177790

EP1177790 - THERAPY WITH CANNABINOIDS IN THE TREATMENT OF CEREBRAL TUMOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.03.2006
Database last updated on 13.11.2024
Most recent event   Tooltip20.04.2007Lapse of the patent in a contracting state
New state(s): ES		published on 23.05.2007  [2007/21]
Applicant(s)For all designated states
UNIVERSIDAD COMPLUTENSE DE MADRID
Rectorado
Avenida de Séneca, 2
E-28040 Madrid / ES
[N/P]
Former [2002/06]For all designated states
UNIVERSIDAD COMPLUTENSE DE MADRID
Rectorado Avenida de Séneca, 2
E-28040 Madrid / ES
Inventor(s)01 / GUZMAN PASTOR, Manuel, Facultad Cc. Biologicas
Dpto. Bioquimica y Biologia Molecular I
E-28040 Madrid / ES
02 / SANCHEZ GARCIA, Cristina, Facultad Cc. Biologicas
Dpto. Bioquimica y Biologia Molecular I
E-28040 Madrid / ES
03 / GALVE ROPERH, Ismael, Facultad Cc. Biologicas
Dpto. Bioquimica y Biologia Molecular I
E-28040 Madrid / ES
 [2002/06]
Representative(s)Carpintero Lopez, Francisco
Herrero & Asociados, S.L.
Agustín de Foxá, 4-10
28036 Madrid / ES
[N/P]
Former [2002/06]Carpintero Lopez, Francisco
HERRERO & ASOCIADOS, S.L. Alcalá, 35
28014 Madrid / ES
Application number, filing date00976087.722.11.2000
[2002/06]
WO2000ES00450
Priority number, dateES2000000032311.02.2000         Original published format: ES 200000323
[2002/06]
Filing languageES
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0158445
Date:16.08.2001
Language:EN
[2001/33]
Type: A1 Application with search report 
No.:EP1177790
Date:06.02.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 16.08.2001 takes the place of the publication of the European patent application.
[2002/06]
Type: B1 Patent specification 
No.:EP1177790
Date:11.05.2005
Language:EN
[2005/19]
Search report(s)International search report - published on:ES16.08.2001
ClassificationIPC:A61K31/352, A61K35/78, A61P35/00, A61P25/00
[2002/06]
CPC:
A61K31/352 (EP); A61K36/185 (EP); A61P25/00 (EP);
A61P35/00 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2005/19]
Former [2002/06]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:THERAPEUTISCHE ANWENDUNG VON CANNABINOIDEN ZUR HIRNTUMORBEHANDLUNG[2002/06]
English:THERAPY WITH CANNABINOIDS IN THE TREATMENT OF CEREBRAL TUMOR[2002/06]
French:THERAPIE FAISANT APPEL A DES CANNABINOIDES POUR LE TRAITEMENT DE TUMEURS DU CERVEAU[2002/06]
Entry into regional phase01.11.2001Translation filed 
02.11.2001National basic fee paid 
02.11.2001Designation fee(s) paid 
02.11.2001Examination fee paid 
Examination procedure02.11.2001Examination requested  [2002/06]
31.07.2003Despatch of a communication from the examining division (Time limit: M04)
26.11.2003Reply to a communication from the examining division
17.02.2004Despatch of a communication from the examining division (Time limit: M04)
14.05.2004Reply to a communication from the examining division
15.07.2004Communication of intention to grant the patent
03.11.2004Fee for grant paid
03.11.2004Fee for publishing/printing paid
07.12.2004Despatch of a communication from the examining division (Time limit: M02)
04.01.2005Reply to a communication from the examining division
Opposition(s)14.02.2006No opposition filed within time limit [2006/18]
Fees paidRenewal fee
03.12.2002Renewal fee patent year 03
27.11.2003Renewal fee patent year 04
10.11.2004Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.11.200203   M06   Fee paid on   27.01.2003
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT11.05.2005
BE11.05.2005
CH11.05.2005
FI11.05.2005
LI11.05.2005
NL11.05.2005
TR11.05.2005
DK11.08.2005
GR11.08.2005
SE11.08.2005
PT19.10.2005
CY22.11.2005
IE22.11.2005
ES23.11.2005
LU30.11.2005
MC30.11.2005
[2007/21]
Former [2007/20]AT11.05.2005
BE11.05.2005
CH11.05.2005
FI11.05.2005
LI11.05.2005
NL11.05.2005
TR11.05.2005
DK11.08.2005
GR11.08.2005
SE11.08.2005
PT19.10.2005
CY22.11.2005
IE22.11.2005
LU30.11.2005
MC30.11.2005
Former [2007/08]AT11.05.2005
BE11.05.2005
CH11.05.2005
FI11.05.2005
LI11.05.2005
NL11.05.2005
TR11.05.2005
DK11.08.2005
GR11.08.2005
SE11.08.2005
PT19.10.2005
IE22.11.2005
LU30.11.2005
MC30.11.2005
Former [2006/51]AT11.05.2005
BE11.05.2005
CH11.05.2005
FI11.05.2005
LI11.05.2005
NL11.05.2005
TR11.05.2005
DK11.08.2005
GR11.08.2005
SE11.08.2005
PT19.10.2005
IE22.11.2005
MC30.11.2005
Former [2006/48]AT11.05.2005
BE11.05.2005
CH11.05.2005
FI11.05.2005
LI11.05.2005
NL11.05.2005
DK11.08.2005
GR11.08.2005
SE11.08.2005
PT19.10.2005
IE22.11.2005
MC30.11.2005
Former [2006/30]AT11.05.2005
BE11.05.2005
CH11.05.2005
FI11.05.2005
LI11.05.2005
NL11.05.2005
DK11.08.2005
GR11.08.2005
SE11.08.2005
PT19.10.2005
MC30.11.2005
Former [2006/22]AT11.05.2005
BE11.05.2005
CH11.05.2005
FI11.05.2005
LI11.05.2005
NL11.05.2005
DK11.08.2005
GR11.08.2005
SE11.08.2005
PT19.10.2005
Former [2006/14]AT11.05.2005
BE11.05.2005
CH11.05.2005
FI11.05.2005
LI11.05.2005
DK11.08.2005
GR11.08.2005
SE11.08.2005
PT19.10.2005
Former [2006/13]AT11.05.2005
BE11.05.2005
FI11.05.2005
DK11.08.2005
SE11.08.2005
Former [2005/52]FI11.05.2005
SE11.08.2005
Former [2005/50]SE11.08.2005
Cited inInternational search[X]  - HARRIS L.S. ET AL., "Retardation of tumor growth by delta-9 tetrahydrocannabinol", THE PHARMACOLOGIST, (1974), vol. 16, no. 2, page 259, XP000957658
 [X]  - BRAUDE M.C. & STEPHEN SZARA, Pharmacology of marihuana, NEW YORK, NY, USA, RAVEN PRESS, (1976), XP000957683 [X] * Proceedings of the meeting Savanah, GA, USA, Dic. 3-6, 1974. Illus., vol 1 y 2-A monograph of the national institute of drug abuse, ISBN 0-89004-067-2, HARRIS, L.S. et al.: "Anti-tumor ..."; page 749 - page 762 *
 [X]  - BAEK SEUNG-HWA, ET AL., "Synthesis and antitumor activity of cannabigerol", ARCHIVES OF PHARMACOL. RES., SEOUL, (1996), vol. 19, no. 3, pages 228 - 230, XP000979791

DOI:   http://dx.doi.org/10.1007/BF02976895
 [X]  - BAEK SEUNG-HWA, ET AL., "Boron trifluoride etherate on silica-A modified Lewis acid reagent (VII). Antitumor activity of cannabigerol against human oral epitheloid carcinoma cells", ARCHIVES OF PHARMACOL. RES., SEOUL, (199806), vol. 21, no. 3, pages 353 - 356, XP000957635
 [A]  - RUIZ L. ET AL., "Delta-9 tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism", FEBS LETT., (1999), vol. 458, no. 3, pages 400 - 404, XP000981226

DOI:   http://dx.doi.org/10.1016/S0014-5793(99)01073-X
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.